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Abstract
We have previously described a new family of mutant adenoviruses carrying different combinations of attB/attP sequences
from bacteriophage PhiC31 flanking the Ad5 packaging domain. These novel helper viruses have a significantly delayed viral
life cycle and a severe packaging impairment, regardless of the presence of PhiC31 recombinase. Their infectious viral titers
are significantly lower (100–1000 fold) than those of control adenovirus at 36 hours post-infection, but allow for efficient
packaging of helper-dependent adenovirus. In the present work, we have analyzed which steps of the adenovirus life cycle
are altered in attB-helper adenoviruses and investigated whether these viruses can provide the necessary viral proteins in
trans. The entry of attB-adenoviral genomes into the cell nucleus early at early timepoints post-infection was not impaired
and viral protein expression levels were found to be similar to those of control adenovirus. However, electron microscopy
and capsid protein composition analyses revealed that attB-adenoviruses remain at an intermediate state of maturation
36 hours post-infection in comparison to control adenovirus which were fully mature and infective at this time point.
Therefore, an additional 20–24 hours were found to be required for the appearance of mature attB-adenovirus.
Interestingly, attB-adenovirus assembly and infectivity was restored by inserting a second packaging signal close to the
right-end ITR, thus discarding the possibility that the attB-adenovirus genome was retained in a nuclear compartment
deleterious for virus assembly. The present study may have substantive implications for helper-dependent adenovirus
technology since helper attB-adenovirus allows for preferential packaging of helper-dependent adenovirus genomes.
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Introduction
Adenovirus (Ad) is one of the most studied vectors in gene therapy
and the most widely used vector in human clinical trials (http://
www.wiley.co.uk/genmed/clinical). Helper-Dependent Ad (HD-
Ad) alternatively referred to as Gutted, Gutless or High Capacity
Ad, are promising vectors for gene delivery. The lack of any viral
coding region in these vectors allows prolonged transgene
expression due to a minimization of cellular immune responses
[1,2,3]. In addition, they are able to incorporate genes up to 36 Kb
in size. A helper virus is required in order to produce HD-Ad to
provide all viral proteins in trans. Nevertheless, the production of
infectious helper virus using this system must be inhibited. The use
of recombinases to specifically excise the packaging domain (y) in
the helper Ad genome represented an important advancement in
HD-Ad production technology [4,5]. At present, the most successful
HD-Ad production system is based on excision of y from the helper
virus genome mediated by Cre recombinase in combination with
the physical separation of helper and HD-Ad virions by
ultracentrifugation. Using this optimized system, levels of helper
Ad contamination can, at best, be reduced to 0.1% 0.01% [6]
(routinely about 1% -0.1%), the main limitation being the
incomplete excision of y due to relatively low levels of Cre in
adenovirus producing cells [7]. Of note, alternative packaging
domain excision-based methods using recombinases such as FLPe
has not resolved this issue [8,9].
To address the limitations of the existing systems, we had
previously reported a non-excision method based on the
differential packaging efficiency between helper Ad and HD-Ad
genomes mediated by the attB sequence of bacteriophage PhiC31
inserted between the inverted terminal repeat (ITR) and the
packaging domain in the helper Ad genome [10]. The helper Ad
packaging process is impaired 36 hours post-infection (hpi)
rendering 100–1000 times lower attB-Ad titers due to a significant
delay in the viral life cycle. This delay is extended up to 56–60 hpi.
Interestingly, attB-FC31 technology is not dependent on the action
of recombinases and, therefore, the generation of new recombi-
nase-based cell lines can be avoided.
Ad has a strictly regulated infection cycle where multiple viral
and cellular proteins interact to complete the viral replication
program to generate infectious virus particles. In vitro, initiation of
infection for Ad5 typically occurs when the fiber knob binds to the
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19564
coxsackie and adenovirus receptor (CAR) in the cell membrane (or
other receptors depending on the Ad5 protein [11] or the Ad
serotype [12]), and penton base binds to alphavbeta3 or
alpgavbeta5 integrins leading to clathrin-mediated endocytosis
[13]. After internalization, Ad5 escapes from the endosome
following pH-acidification leading to viral capsid disassembly.
Adenovirus particles traffick through the cell along the microtu-
bule network [14] and reach the nucleus through nuclear pores
[15]. Finally, adenovirus expresses the proteins required for viral
genome replication and subsequent processes of the viral life cycle.
Of note, genome replication and capsid assembling events occur in
different nuclear compartments [16].
Packaging of the adenoviral genome is a complex process where
different viral proteins, (e.g. L1-52/55K, IVa2 and L4-22K),
interact with y to encapsidate the viral genome in a polar process
to form a mature viral particle [17]. Interestingly, the packaging
domain can be located at either end of the viral genome allowing
for viral genome packaging. The distance of y from the 59 or 39
ends of the genome is crucial for optimal packaging activity,
although some flexibility in its location is tolerated. For example,
when the distance between the ITR and y is 655 nucleotides or
more, virus viability is severely compromised. However, when the
distance between the ITR and y is increased up to 271
nucleotides, fully viable viruses are produced [18]. During the
Ad assembly process, the density of the viral particle varies from
1.29 to 1.35 g/cc which appears to reflect the insertion of viral
DNA into an empty capsid, the subsequent packaging process,
followed by final virion maturation [17]. The Ad protease, also
called adenain, is transported into the capsid and mediates the
final steps of mature particle formation via the cleavage of a
number of virion proteins including pIIIa, pVI, pVII, pVIII, pTP,
X and L1-52/55K [19].
For final application of attB-helper adenoviruses in HD-Ad
production, an extensive characterization of these vectors is
required. Here, we have investigated which processes of the attB-
helper Ad viral life cycle are affected.
Methods
Adenovirus generation, production and purification
Ad5/attP, Ad5/RFP, Ad5/bgal and attB-helper Ads (Ad5/
FC31.1 or Ad5/FC31.2) were produced at the Vector Production
Unit in the Center of Animal Biotechnology and Gene Therapy at
the Universitat Auto`noma de Barcelona (Bellaterra, Spain) as
previously described [10]. Briefly, PacI-linearized plasmids were
transfected into HEK293 cells (ATCC, CRL-1573) and virus
recovered 8–10 days post-transfection. Then, viruses were
amplified through successive 56–60 hour infection cycles until a
total of 46108 HEK293 cells were infected. Ad5/FC31.1[y] was
generated using Stow’s method [20], by cotransfecting PacI-
linearized pAd5/FC31.1 plasmid and in340 virus complete
genome (with the exception of the left terminus). Plaques were
isolated and different clones were amplified to generate Ad5/
FC31.1[y] as previously described. Viral mutant Ad5/ts369 was
produced in HEK293 cells grown at 32.5uC. Viruses were purified
using two consecutive CsCl gradients (a step gradient followed by
an equilibrium gradient [21]) followed by elution on a Sephadex
PD-10 desalting column (Amersham Biosciences, Uppsala,
Sweden). For attB-helper Ads, both, mature and immature
particles from the first gradient were purified in the second cesium
chloride gradient. Final purified viral stocks were titered by
determining their concentration (particles/ml) by optical density at
260 nm (1 OD260 unit = 161012 particles/ml), and their
infectivity (infectious units/ml) was measured by endpoint dilution
assay. Briefly, end-point dilution assays were performed in
triplicate by infecting 293 cells with serially diluted vectors, and
then counting the number of transgene (GFP, RFP or bgal)
expressing cells. Viral titers ranged between 0.761010 to
361010 IU/ml with an average ratio of physical particles to
infectious units of 40:1.
Viral production assay
HEK-293 cells were infected with control Ad and attB-helper
Ad at 5 IU/cell in a 6-well format. Fresh DMEM medium was
added 6 hpi. Pellet and supernatant were harvested at 36 and
56 hpi and three rounds of freeze/thawing performed to liberate
viral particles. Finally, infectious titer was calculated at each time
point by end-point dilution assay in three independent analysis.
Southern Blot analysis of viral genomes
High molecular weight DNA was extracted following Hirt’s
Method [22]. For packaged genomes, DNA was extracted from
10 ml of purified virus or from 200 ml of crude viral lysate.
Fourteen ml of 10% SDS, 6 ml of 0.5 M EDTA and 40 ml of
20 mg/mL proteinase K (Roche,) were added. Samples were
incubated for 3 hours at 55uC and later heated for 5 min at 95uC
to liberate viral genomes. Samples were then diluted to 200 ml with
deionized water and 100 ml of 7.5 M ammonium acetate added.
Viral DNA was extracted using 300 ml of Phenol/CHCl3/isoamyl
alcohol (25:24:1) and absolute ethanol, then precipitated by
washing twice with ethanol 70%. Pellets were then dissolved in
50 ml of sterile deionized water. SpeI-digested viral genomes were
separated by gel electrophoresis, and then incubated in: a)
200 mM HCl (15 min); b) 5 N NaOH, 1.5 M NaCl (45 min); c)
206 SSC buffer (NaCl 3 M, Sodium Citrate 0.3 M pH=7.4)
(45 min). DNA was transferred to a positively-charged membrane
(Roche Diagnostics Corp, Indianapolis) in 106 SSC buffer for
18 hours, fixed via exposure to UV light with a UV-stratalinker
1800 (Stratagene, La Jolla, CA) and detected using Alkphos Direct
Labelling kit (Amersham Biosciesces) according to manufacturer’s
instructions.
Viral replication assay
Both Ad5/attP and Ad5/FC31.1 were used to infect HEK-293
cells at 5 IU/cell in a 6 well plate for 6 hours, in two independent
experiments. Cell were washed and fresh medium added. Cell
pellets/supernatants were recovered at 24, 28, 32 and 36 hpi.
Viral DNA was extracted from one tenth of the crude lysate and
transferred to a Hybond-XL membrane (Amershan Biosciences)
and detected using a GFP probe (at concentrations ranging from
50 to 0.01 ng). The GFP probe was obtained by isolating a
1597 bp product corresponding to the GFP expression cassette of
pKS/RSV (kindly provided by Eric Kremer, Montpellier, France)
using a SpeI+SalI restriction digest. The product was then labelled
with AlkPhos Direct Labeling Kit and used to probe viral DNA
using the DP-Star detection kit according to the manufacturer’s
instructions. In parallel, crude lysates from infected cells were
analyzed in triplicate by end-point dilution assay to calculate the
number of IU/cell at each time point.
Co-infection assay
HEK-293 cells were infected with Ad5/attP, Ad5/FC31.1 and
Ad5/FC31.2 (all carrying a GFP cassette) or Ad5/bgal Ad
(carrying a bgal cassette) in a 6-well plate at 5 IU/cell for single
infection. For co-infection experiments attB/attP-modified Ads
(Ad5/attP, Ad5/FC31.1 and Ad5/FC31.2) were co-infected with
control Ad5/bgal at 5 IU/cell per virus. At 36 hpi, viruses were
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harvested and further titered by end-point dilution assay using
fluorescence microscope and X-gal staining for GFP or bcal
viruses respectively.
Flow Cytometry
46106 HEK293 cells were infected (n = 5) with different control
and helper Ad (MOI=2). Infected cells were recovered at 12, 24,
30 and 36 hpi. Medium was recovered and saline buffer was
added to harvest the cells. After centrifugation, cells were first
resuspended in PBS buffer (16) and then in 4% paraformaldehyde
buffer. Finally, GFP expression by infected cells was analyzed by
flow cytometry at Servei de Citometria of IBB-UAB (Universitat
Auto`noma de Barcelona).
Electron Microscopy assay
Viral particles were analyzed by the Uranyl Acetate method as
previously described [23]. The samples were viewed with a FEI
Tecnai 12 BioTwinG2 transmission electron microscope at 80 kV
and the digital images were obtained with an AMT XR-60 CCD
Digital Camera System. Services were provided by the TEM
Facility, Central Microscopy Imaging Center at Stony Brook
University, Stony Brook, New York, USA.
Silver Stain SDS-PAGE protein analysis
Viral proteins from virions purified by CsCl equilibrium
gradient centrifugation were separated by electrophoresis on a
SDS-10% polyacrylamide gel and silver stained as previously
described [24]. Gels of viral proteins were incubated with 50%
methanol/10% acetic acid followed by 10% methanol/5% acetic
acid incubation, dithiothreitol, and 12 mM silver nitrate. Signal
was developed by incubation in 2% potassium carbonate
containing 0.044% formaldehyde, and development stopped by
incubation in 1% acetic acid. Finally, the gel was washed with
distilled water.
Western Blot and immunodetection analysis
Viral proteins were separated by SDS-polyacrylamide gel
electrophoresis and transferred to a Hybond-P membrane
(Amersham-Pharmacia) by standard methods, in at least two
independent experiments. Membranes were probed with antibod-
ies directed against penton base and hexon (generous gifts of Carl
Anderson, Brookhaven National laboratory, USA), L1-52/55K
[25], pVII/VII [26] and b-actin (ref. a2066, Sigma). Proteins were
visualized using AlkPhos-coupled secondary antibody (Zymed) and
a fluorescent substrate (AttoPhos Substrate, Promega). Signals
were analyzed using a phosphorimager (Molecular Dynamics
Storm 860).
EMSA assay
Nuclear extracts prepared from HEK293 and DKzeo cells [27]
were in HEPES 20 mM at pH 7.5, glycerol 20%, NaCl 450 mM
MgCl2 1.5 mM, EDTA 0.2 mM in sterile deionized water and
protease inhibitors, following the protocol described by Zhang et
al [28], and stored at 280uC. Protein extracts were quantified
using BCA following the manufacturer’s protocol (Pierce). Three
mg of nuclear extract were incubated for 30 minutes at 37uC with
2.6 ml 56 Binding buffer (LightShift Chemiluminescent EMSA
Kit, 20148X, Pierce), 1 ml poly-deoxyinosic-deoxycytidylic, and
1 ml of biotin-labeled wild type-attB or mutant attB. The samples were
then separated in a non-denaturing polyacrylamide gel for
90 minutes at 120 V, and transferred to a positively charged
membrane (Roche Diagnostics Corp, Indianapolis,). Subsequently
the membrane was incubated with a peroxidase-streptavidin
conjugate, followed by washing and incubation with luminol
(PIERCE) following the protocol provided by the manufacturer.
To confirm observations, the experiment was repeated in three
independent analysis. attBwt sequence (wild type): 59ACCGG-
TCCGCGGTGCGGGTGC CAGGGCGTGCCCTTGGGCT-
CCCCGGGCGCGTACTCCAC39. attB* sequence (mutant): 59-
ACCGGTGGGCACGCGCGCACCTGGCGCACCGCGTC-
GGCGCACCTGCGCACCTG GCACCA39.
Statistical Analysis
Statistical calculations were performed using the G-Stat version
2.0 statistical program. Statistical significance was determined by
one way ANOVA test with P value set at #0.05. Data are
presented as mean 6 SD unless stated otherwise.
Results
attB/attP sequences flanking the packaging signal do not
affect the entry of the adenoviral genome into the
nucleus
The recombinant viruses used in this study include viruses with
RFP (Ad5/RFP) or GFP (Ad5/attP, Ad5/FC31.1, Ad5/FC31.2)
expression cassettes in place of the E1 region. Ad5/attP contains a
PhiC31 attP site located to the right of the GFP gene. Ad5/FC31.1
and Ad/FC31.2 contain the same attP insertion as well as an
additional PhiC31 attB site inserted to the left of the Ad5
packaging domain and differ only by the additional insertion of a
65-bp spacer between attB and y in Ad5/FC31.2 (Fig. 1). We
previously reported that the attB insertion, but not the attP
insertion, reduced viral DNA packaging, delayed the production of
infectious virus and decreased overall infectious virus yield [10].
Here, we characterize this defect in further detail. Entry of attB-Ad
genomes (adenovirus vectors carrying the attB sequence 59 of the
packaging signal) into the nucleus was compared to control first
generation Ad5/RFP by infecting HEK293 cells at a multiplicity
of infection (MOI) of 5 infectious units per cell (Figure 2A). Viral
genomes were isolated by Hirt’s method from the nucleus at 6 hpi.
Southern blot densitometry showed that both viral genomes of
control and attB-Ad vectors reached the nucleus at similar levels,
indicating that viral proteins involved in virion trafficking must be
present and fully active in attB-Ad.
Figure 1. Adenovirus constructs used in this work containing
the packaging signal flanked by different combinations of
attB/attP sequences and a reporter expression cassette. Viral
genomes schemes are not to scale.
doi:10.1371/journal.pone.0019564.g001
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Viral DNA replication and protein production of attB-
adenovirus are not affected
To analyze whether viral DNA replication was altered, viral
genome replication was quantified at 24, 28, 32 and 36 hours post
infection (hpi) and correlated with infectious virus yields at the
same time points. HEK-293 cells were infected with attB-Ad and
Ad5/attP (control Ad) at a MOI of 5, and viral DNAs purified and
quantified by dot-blot analysis. We found that for both attB-Ads,
the kinetics and level of genome replication were similar to Ad5/
attP at all time points (Ad5/FC31.1, Figures 2B and 2C; Ad5/
FC31.2, data not shown). However, the amount of infectious attB-
Ad (in IU/cell) was markedly reduced (.99%) at all times
compared to control Ad, and statistically significant (p,0.01 at 24,
28 and 36 hpi; and p,0.001 at 32 hpi). These results showed that
the delayed life cycle of attB-Ads must be due to alterations in
subsequent steps to replication. Moreover, since Ad5/FC31.1 and
Ad5/FC31.2 vectors are identical (except for an extra 65-bp
spacer between attB and y in Ad5/FC31.2) and have a similarly
delayed viral life cycle (Reference 8, Figure 3), as well as similar
viral infectivity and DNA replication, they were used interchange-
ably throughout the experiments.
In addition to viral replication, the levels of expression of several
viral proteins from the Ad5/bgal, Ad5/attP or attB-Ad genomes
were also analyzed. Both the GFP-marker protein (driven by a
constitutive promoter and analyzed at 24, 30 and 36 hpi;
Figure 3A) and Ad5 hexon protein (driven by the endogenous
adenoviral MLP promoter and analyzed at 24 hpi; Figure 3B)
were expressed at similar levels from the attB-Ads compared to the
control Ads. These results support our notion that the delayed
maturation of attB-Ad is due to effects on life cycle steps following
viral genome replication.
Adenovirus proteins provided in trans do not normalize
the viral life cycle of attB-Ad vectors
Previous results showed that attB-Ads could rescue HD-Ad
vectors [10] and are in agreement with results here suggesting that
the defect in attB-Ads is a cis-acting effect. We examined this issue
by testing whether the delay in the accumulation of infectious attB-
Ad could be rescued by co-infection with a control adenovirus.
attB-Ads and Ad5/attP (carrying a GFP cassette) were co-infected
with a first generation adenovirus (Ad5/bgal) and analyzed at
36 hpi. As expected, single infections of control Ad5/attP or
control Ad5/bgal (MOI of 5) generated titers 100–200-fold higher
than those from attB-Ad vectors (Figure 4). Similarly, in co-
infection experiments using Ad5/bgal (MOI of 5) either with attB-
Ad (MOI of 5) or with control Ad5/attP (MOI of 5), only modest
changes in viral titers (either of Ad5/bgal, Ad5/attP or attB-Ad)
compared to the single virus infection were observed. These data
Figure 2. Southern Blot analysis of Ad5/RFP and attB-genome at 6 hpi in 16107 HEK293 cells (MOI=5) Equal amounts (30 mg) of
high molecular weight DNA were loaded. Probe used contains the first 194 nt of adenovirus genome. (B) Viral genome replication of Ad5/attP and
attB-Ad. Viral DNA produced at 24, 28, 32 and 36 hpi in HEK-293 cells (MOI = 5) were quantified by Dot-Blot in triplicate and titers measured in
nanograms (ng) of DNA. (C) Virus yield of Ad5/attP and attB-Ad. Infectivities of vectors were analyzed in triplicate, and further quantified in IU/cell (in
bars) by fluorescent microscopy after a secondary infection in HEK-293 cells. Statistics were performed with natural log values using one way ANOVA
(** p,0,01; *** p,0,001).
doi:10.1371/journal.pone.0019564.g002
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(A)  
show that the delay in accumulation of infectious attB-Ad cannot
be rescued (or rescued only in a minor fraction) to levels of control
Ad5/attP (p,0.05 for both attB-Ad vectors) by the presence of
viral proteins provided in trans by an Ad vector with a normal life
cycle.
Altered viral capsid formation of attB-Ad vectors at
36 hpi
Since the delay in the accumulation of mature attB-Ad was
independent of replication and expression of the structural
proteins, we examined the integrity and formation of adenoviral
capsids by electron microscopy (Figure 5). As controls, Ad5/RFP
and Ad5/ts369 were analyzed at 36 hpi and attB-virus was
analyzed at 36 and 56 hpi. Ad5/ts369 is an L1-52/55K
temperature-sensitive mutant virus that is blocked at an interme-
diate stage when grown at the non-permissive temperature of
39.5uC [29]. It accumulates light intermediate particles and was
used as a control for intermediate virus assembly. Interestingly, at
36 hpi attB-Ad appeared to be in an intermediate state of assembly
which resembled Ad5/ts369 grown at the non-permissive
temperature. Protein aggregates were observed along with
relatively few virus-like particles. The particles appeared to lack
DNA since they accumulated uranyl acetate in the interiors.
However, at 56 hpi, most attB-Ad capsids appeared mature and
resembled those observed for control Ad5/RFP at 36 hpi
(Figure 5).
Maturation of attB-Ad particles is severely impaired at
36 hpi
Inefficient virus maturation was also evident during the
purification process on cesium choride gradients. Ad5/FC31.2
(36 hpi) produced mainly immature particles compared to control
Ad5/RFP (36 hpi) or Ad5/FC31.2 at 56 hpi (Figure 6A). Results
of a second isopycnic cesium chloride gradient centrifugation of
Ad5/FC31.2 (56 hpi) revealed the presence of at least three
immature intermediates of maturation, termed Band 1, Band 2
and Band 3, (Figure 6B) which were individually isolated for
further characterization. Of note, density of the purified Ad5/
FC31.2 (36 hpi) particles was significantly lower with respect to
Figure 3. Analysis of protein expression. HEK-293 cells were
infected with Ad5/bgal, Ad5/attP or attB-Ad at MOI of 5, and samples
were analyzed at 24, 30 and 36 hpi. Non-viral marker GFP protein was
quantified by measuring relative mean fluorescence intensity per cell
(RFU/cell) by Flow Cytometry (A). Late viral hexon protein was detected
from protein extracts by Western Blot analysis at 24 hpi (B). Equal
amount of proteins were loaded and b-actin protein was used as
control. Mock are uninfected HEK-293 cells.
doi:10.1371/journal.pone.0019564.g003
Figure 4. Co-infection experiments using Ad5/bgal and attB/attP vectors (Ad5/attP and attB-genomes, all expressing GFP). HEK-293
cells were infected at 5 IU/cell for each adenovirus vector (‘‘single infection’’), or co-infected with Ad5/bgal and different attB/attP-containing vectors
(5 IU/cell each vector). (a) Refers to Ad5/bgal coinfected with Ad5/attP; (b) to Ad5/bgal coinfected with Ad5/FC31.1; and (c) to Ad5/bgal coinfected
with Ad5/FC31.2. At 36 hpi, virus were harvested and further titered by end-point dilution and analyzed in triplicate by bgal or GFP expression in two
independent experiments. Asterisks refers to statistical significance: * p,0,05; ** p,0,01.
doi:10.1371/journal.pone.0019564.g004
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Ad5/RFP (36 hpi) and Ad5/FC31.2 (56 hpi) particles densities
(Figure 6C).
The virus maturation process was analyzed in detail by silver
staining of viral proteins of purified particles of Ad5/RFP (36 hpi),
Ad5/ts369 (36 hpi) grown at the nonpermissive temperature and
attB-Ad (36 and 56 hpi) (Figure 6D). The protein banding pattern
of attB-Ad at 36 hpi was similar to that of the Ad5/ts369 light
intermediate particle protein pattern. Both showed the presence of
precursor proteins including pVI, pVIII and 50K. In contrast, at
56 hpi attB-Ad presented a similar protein pattern to Ad5/RFP
(e.g., the loss of the 50K protein). However, not all attB-Ad
particles were fully mature since pVI and pVIII precursors were
still detected.
L1-52/55K has been shown to be cleaved during the assembly
process; likely by adenain [16]. Intermediate and empty particles
contain intact L1-52/55K as well as cleaved products of
approximately 40 KDa, while the mature virus lacks intact L1-
52/55K and is markedly reduced for the 40K product. Western
blot analysis for L1 52/55K of Ad/RFP, Adt5/ts369 and attB-Ad5
indicated that at 36 hpi, particles of Ad/RFP did not contain
intact L1-52/55K (although the 40K cleavage products were
observed); while light intermediate particles of Ad5/ts369 grown
at the non-permissive temperature contained both the intact and
cleaved product(s) of L1-52/55K (Figure 7A). However, at 36 hpi
attB-Ad produced very low levels of L1-52/55K, suggesting that
only few capsids had incorporated this protein. At 56 hpi, the level
of cleaved L1-52/55K proteins increased, though a significant
percentage remained uncleaved (54%) indicating that part of the
attB-Ad viral population was still at an intermediate step of
maturation. Analysis of pVII showed that at 36 hpi attB-particles
had similar levels of precursor and mature protein VII (60% to
40%, respectively), while at 56 hpi protein VII was mature
(Figure 7B). As expected, protein VII was unprocessed in the
immature particles isolated from Band 2 and 3 (Figure 6B) and not
present in Band 1, indicating that these putative intermediates
corresponded to capsids at the very early steps of maturation
(Figure S1). In addition, material from these bands did not contain
viral DNA and were not infectious.
A second packaging signal cloned at 39-ITR normalizes
infectivity levels of attB-Ad
To determine whether the defect in virus assembly observed
with attB-Ad was due to a dominant effect mediated by the attB
sequence we generated a new Ad construct named Ad5/
FC31.1[y] with a second packaging domain inserted at the
right-end of the genome (Figure 1). Results of infections showed
that at 36 hpi similar levels of infectious viral particles of Ad5/
FC31.1[y] as compared to the control Ad (Ad5/bgal) were
obtained (Figure 8) indicating that Ad5/FC31.1[y] capsids were
fully matured at that time. This result show Ad5/FC31.1[y] viral
genomes allow for normal genome replication and viral protein
expression at 36 hpi, suggesting that the delayed attB-helper
Figure 5. Electron microscopy analysis of CsCl-purified Ad5/ts369 and Ad5/RFP viruses at 36 hpi and attB-Ad at 36 and 56 hpi in
HEK293 cells. Uranyl acetate staining was used to visualize viral particles. Representative sections among multiples pictures are shown. Bar equals
500 nm on top row and 100 nm in bottom row.
doi:10.1371/journal.pone.0019564.g005
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genome life cycle is not due to irreversible trapping in a nuclear
compartment that inhibits virus assembly.
A nuclear protein interacts with the attB sequence in
vitro
Taken together the results, with Ad-helper vectors with the attB
sequence 59 of the packaging signal having a delayed viral cycle
leads to the hypothesis that a cellular factor could be interacting
with the attB sequence, impairing the formation of the packaging
complex with y. In order to test this hypothesis an electrophoretic
mobility shift assay (EMSA) was performed to detect specific
interactions mediated by nuclear protein(s). In addition to the wild
type attB sequence, we also tested a mutant attB sequence encoding
the same nucleotide composition as the wild type attB but in a
different order. Results clearly show that in vitro, the wild type attB
sequence (but not the mutant attB) interacts with a nuclear protein
from HEK293 cells (Figure 9). In order to test whether this
interaction was specific for the HEK293 cell line, we also tested
the interaction between the attB sequence and protein extracts
from canine DKZeo cells. The band-shift also observed in DKzeo
cells (data not shown), indicating that this interaction was not
specific for HEK293 cells. The band-shift in HEK-293 cells
appeared to be more intense than in DKzeo cells, suggesting
different levels of expression for this nuclear factor between both
cell types.
Discussion
Helper-dependent adenovirus vectors are important candidates
for gene therapy due to their reduced capacity to induce cellular
immune responses and their ability to direct stable transgene
expression of up to 2 years [30]. Despite these advantages, their
production presents two important problems: (1) contamination
with helper Ad and (2) low titer preparations. During the last
decade, optimization of the Cre-loxP system has been done by
combining the excision of y (using a Cre expressing cell line) with
the physical separation of helper and HD-Ad virions by density in
CsCl ultracentrifugation. This has improved the reduction of
helper Ad contamination levels from 10% down to 0.1%-0,01%
[6]. Additional strategies for optimizin the excision of y mediated
by Cre recombinase must consider the compromise required
between recombination activity and cell toxicity, i.e. low Cre levels
limit efficient excision of y, while high Cre levels become cytotoxic
and affect proliferation of adenovirus producing Cre-cell lines [7].
Moreover, the need for large amounts of HD-Ad vectors for
clinical assays in human patients prevents the use of non-scalable
downstream processes such as ultracentrifugation. Therefore, to
Figure 6. Results of first cesium chloride gradient (A). Shown are images for Ad5/RFP and Ad5/FC31.2 at 56 hpi and Ad5/FC31.2 at 36 hpi.
Arrows indicate (a) mature particles, and (b) immature particles. (B) Second cesium chloride gradient for Ad5/FC31.2 at 56 hpi, 1, 2 and 3 indicates
three low density bands. (C) Density in (g/cm3) of purified particles of Ad5/RFP, Ad5/ts369, Ad5/FC31.2 at 36 hpi and Ad5/FC31.2 at 56 hpi. (D) Silver
stained polyacrylamide gel of CsCl purified particles of Ad5/ts369 and Ad5/RFP at 36 hpi. and attB-Ad at 36 and 56 hpi. Asterisks refers to statistical
significance: * p,0,05; ** p,0,01.
doi:10.1371/journal.pone.0019564.g006
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improve production and purification of HD vectors beyond the
limits of current systems, other strategies must be developed.
We have recently generated a new system based on preferential
packaging of the HD-Ad genome compared to the helper Ad
genome. We constructed a family of helper Adenovirus by flanking
the packaging signal with PhiC31 attB/attP sites [10]. At 36 hpi
production yield of attB/attP Ads (in IU/cell) is significantly
reduced (.99%). Surprisingly, though attB and attP sites are
sequences recognized by FC31 recombinase, differential packag-
ing takes place in the absence of recombinase indicating that
mechanism(s) other than recombination are involved.
Here, we have analyzed the mechanism underlying the delayed
viral cycle of attB-Ad by studying the steps in adenovirus particle
generation. We have observed that attB-Ad can reach the cell
nucleus at the same time (6 hpi) and at the same level (genome
copies) as a control Ad (Ad5/RFP). Since at this time replication
has not yet started, thus the observed viral genomes are derived
from the incoming virus. This indicates that attB-Ad viral capsids
allow appropiate cell trafficking and uncoating, and therefore viral
capsid proteins (like adenain and pVII) must be fully active. When
compared to control Ad5, viral DNA replication from attB-Ad and
attP-Ad vectors is slighty reduced (between 0% and 50%, data not
shown). However, this does not affect the kinetics and level of virus
production since Ad5/attP behaves exactly as control Ad5.
Moreover, quantification of viral DNA replication up to 36 hpi
showed that although attB-Ad infectious titers were 2 to 3 logs
lower than those for control attP-Ad, attB-Ad replicated to the
same level as attP-Ad at all time points. Therefore, viral genome
replication is not causing the delay in the attB-Ad viral life cycle.
Analysis of adenoviral gene expression showed that protein
expression levels from attB-Ad were equivalent to controls (Ad5/
attP or Ad5/bgal). Consistent with this result, coinfection of attB-
adenoviral particles with Ad5/bgal, which does not show any
delay in viral life cycle, did not rescue the delay in the attB-Ad5 life
cycle. Furthermore, as previously shown, attB-Ad viruses function
Figure 7. Analysis of L1-52/55K and pVII proteins of attB-adenovirus. (A) Western Blot analysis of penton base (control for protein content)
and L1-52/55K viral proteins from CsCl gradients of Ad5/RFP and Ad5/ts369 at 36 hpi and attB-Ad at 36 and 56 hpi (cleaved and uncleaved L1-52/55K
protein are indicated by arrows). Densitometric analysis of the Western-blot for the L1-52/55K cleaved and uncleaved proteins after normalization to
penton base. (B) Western blot analysis of adenoviral protein pVII from CsCl gradients of Ad5/RFP at 36 hpi and attB-Ad at 36 and 56 hpi.
doi:10.1371/journal.pone.0019564.g007
Figure 8. Effect of a second packaging signal in attB-Ad
production. Viral production in IU/cell of Ad5/FC31.1, Ad5/FC31.1[y]
and Ad5/bgal at 36 hpi. in HEK293 cells. Titering was performed in
triplicate in HEK-293 cells. Asterisks refers to statistical significance: **
p,0,01; *** p,0,001; NS = not significant).
doi:10.1371/journal.pone.0019564.g008
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efficiently as helper virus for the production of HD-Ad vectors
[10]. Therefore, the cause of the delayed viral cycle must reside in
the genome sequence or the viral genome structure of attB-Ad.
The delay in packaging and accumulation of infectious attB-Ad
genomes was rescued by the incorporation of a packaging domain
at the right end of the attB-Ad genome. Therefore, the cis-acting
defect is recessive to the presence of a wild type packaging domain.
This result indicates first, that the attB-helper genome is not
irreversibly retained in a nuclear compartment inhibitory to virus
assembly, and second, that packaging impairment was not caused
by spontaneous and deleterious mutations in the attB-Ad genomes.
We have previously reported that less than 5% of the attB-Ad
genomes are packaged at 36 hpi in coinfection experiments
compared to control viral genomes [10]. Furthermore, only a
minimal fraction of the packaged attB-genomes were able to form
infectious particles at 36 hpi [10]. To test if differences in attB-Ad
infectivity correlated with differences in capsid morphology,
adenoviral capsids were analyzed by electron microscopy. As
observed for the control Ad5/bgal at 36 hpi, the majority of attB-
Ad vectors consisted of full capsids at 56 hpi. In contrast, at
36 hpi, attB-particles were present in an immature state consisting
of protein aggregates and some empty particles; similar to that
observed for the light assembly intermediate mutant Ad5/ts369
grown at the nonpermissive temperature. Since viral proteins
provided by attB-Ad allow normal packaging of HD-Ad at 36 hpi
[10] then, according to the classical theory of adenovirus assembly
[17], pre-formed empty capsids should be also available for the
packaging of attB-Ad genomes at this time. However, instead of
empty capsids, electron microscopy images showed an accumu-
lation of unstructured protein aggregates with few empty capsids.
These results are suggestive of a modified theory; that is, that the
packaging complex on the viral DNA acts as an initiator of the
formation of a procapsid/DNA assemblage followed by the
incorporation of the DNA into the procapsid. Since the attB-Ad
infectious cycle is delayed without mutating any viral proteins of
the packaging complex, these vectors could also be used to study
basic aspects of adenovirus assembly.
The protein content of attB-Ad particles isolated at 36 and
56 hpi was examined. At 36 hpi attB-Ad presented a viral protein
pattern similar to Ad5/ts369 at the restrictive temperature
indicating an intermediate state of virus maturation. In contrast,
the protein pattern of attB-Ad at 56 hpi was similar to control
Ad5/RFP, though a band likely corresponding to pVI/pVIII
precursors was also observed, suggesting that the viral life cycle of
attB-Ad must be slightly longer than 56 hours. Detailed analysis of
two key maturation proteins at 36 hpi showed low amounts of L1-
52/55K (either cleaved or uncleaved), and that only ,50% of
pVII protein was cleaved, consistent with the formation of only a
few attB-helper Ad capsids. However, at 56 hpi, almost all pVII
protein was cleaved, while L1-52/55K levels in attB-Ad particles
were much higher than at 36 hpi. Furthermore, an important
proportion of L1-52/55K was still uncleaved, confirming once
more that attB-Ad had not completed the maturation process at
56 hpi, and that this process may take closer to 60 hours, as
observed from the analysis of their life cycle. Collectively, these
results demonstrate that the insertion of an attB site between the
Ad5 ITR and y hinders viral DNA packaging and consequently
the virion maturation process.
This finding could reflect the altered spacing between y and the
ITR, but there is considerable flexibility allowed in the location of
the packaging signal relative to the genomic terminus, as
demonstrated by Hearing and al. [18], so a spacing effect appears
unlikely. Rather, results from the EMSA experiment suggest a
mechanism by which the attB sequence interferes with virus
assembly and could be related to the binding of a nuclear protein
to this sequence. Due to the proximity of attB site to y, efficient
interaction between packaging complex proteins and y would be
affected by the binding of the unknown nuclear factor to attB.
Indeed further analyses are required to identify the unknown
nuclear factor.
In conclusion, we have demonstrated that the severe delay in
the viral life cycle of attB-Ad helper virus is not caused by
abnormal viral DNA replication nor by altered levels or
availability of viral proteins. However, the packaging process is
clearly impaired and it affects the timing of subsequent processes
such as maturation of the Ad particles. Thus, at 36 hpi we
observed protein aggregates and few unassembled capsids instead
of fully matured particles. Only when production times were
prolonged to 56 hours was it possible to detect a high percentage
of mature and infectious attB-Ad virions. Therefore, these results
may have important implications for HD-Ad vector technology
since this is a novel method based on preferential packaging to
produce infectious HD-Ad particles in the absence of helper Ad
[10]. Most importantly, it avoids the current limitations associated
with standard methods based on recombination-mediated excision
of the packaging signal, since it does not require physical removal
of contaminating helper virions by ultracentrifugation, and allows
the use of scalable downstream methods, such as HPLC
purification. Finally, the impairment on genome packaging and
capsid maturation processes also makes attB-Ad useful vectors for
future studies to better understand the adenovirus life cycle.
Supporting Information
Figure S1 Western blot analysis of adenoviral protein pVII from
CsCl gradients. Ad5/RFP and Ad5/ts369 were harvested at
Figure 9. Enzyme electrophoretic mobility shift assay using
HEK293 cell nuclear extracts. Competitor: HEK293 cell nuclear extracts
incubated with the attBwt sequence together with poly-dIdC and
unlabeled attBwt as specific competitor. NNE: attBwt sequence without
nuclear extracts. attBwt: Nuclear extracts from HEK293 cells incubated
with a wild type attB sequence and poly-dIdC. attB*: Nuclear extracts from
HEK293 cells incubated with a mutant attB sequence and poly-dIdC.
doi:10.1371/journal.pone.0019564.g009
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36 hpi. Ad5/FC31.2 was harvested at 56 hpi. Samples from Ad5/
FC31.2 are the intermediate steps of maturation observed in
figure 6B.
(TIF)
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